biotech

Ignite It
2 min read • October 27, 2022

Israeli Company Clones Cannabis Cells As ‘Wellness And Sustainability’ Solution

Ignite It
3 min read • October 21, 2022

Canopy Growth Corporation’s Ace Valley Debuts Lust And Thrust Cannabis Infused Gummies

Ignite It
4 min read • October 9, 2022

Study Published On Yale Journal Shows Cannabis Provides Immediate Relief For Symptoms Of Depression & Other Mental Health Issues

Ignite It
2 min read • October 5, 2022

Solving The Insoluble: How One Company’s Patented Tech Can Make CBD, Pharma Drugs And Nutraceuticals Water-Soluble

Ignite It
2 min read • September 28, 2022

Medical Implants Could One Day Be Made Of CBD Or Poly Cannabinoids, According To New Study

Ignite It
1 min read • September 26, 2022

Anebulo Pharmaceuticals Announces Interim Data For ANEB-001 From Part B Of Its Phase 2 Clinical Trial For Acute Cannabinoid Intoxication; Says Lower Doses Of ANEB-001 Reduced The Negative Effects Of Higher Doses Of THC

Ignite It
1 min read • September 22, 2022

Meet The Biotech Firm Revolutionizing Cannabis

Ignite It
1 min read • September 16, 2022

India Globalization Capita Just Got FDA Approval To Start Enrolling Their Phase 2 Alzheimer Trial With IGC-AD1, A Cannabis Drug

Ignite It
2 min read • August 28, 2022

Does Weed Affect Sleep? Study Says Heavy Consumers Don’t Sleep The Ideal Amount Of Hours

Ignite It
5 min read • August 15, 2022

Sun, Water, Weed And B2B?: What Opportunities Can Cannabis Investors Expect From This Conference In Panama

Ignite It
6 min read • July 31, 2022

THCP Is A Cannabinoid More Potent Than THC: An In-Depth Look At The Study That Discovered It

Ignite It
2 min read • July 30, 2022

Skunk Smell: Study Reveals Origin Of Marijuana’s Distinctive Aroma

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.